| |
| |
|
| Insider
Information: |
Kutok Jeffery |
| Relationship: |
Chief Scientific Officer |
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
77,376 |
|
|
Indirect Shares
|
10,744 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
88,120 |
|
|
| Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Infinity Pharmaceuticals Inc |
INFI |
Chief Scientific Officer |
2020-01-10 |
77,376 |
2020-01-10 |
10,744 |
Premium* |
|
|
Epizyme, Inc. |
EPZM |
Chief Scientific Officer |
2022-08-12 |
0 |
2020-04-01 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
15 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| EPZM |
Epizyme, Inc. |
Chief Scientific Officer |
• – – |
2022-08-12 |
4 |
D |
$0.00 |
$0 |
D/D |
(120,067) |
0 |
0 |
- |
|
| EPZM |
Epizyme, Inc. |
Chief Scientific Officer |
• – – |
2022-08-09 |
4 |
D |
$1.39 |
$492,749 |
D/D |
(354,496) |
120,067 |
0 |
- |
|
| EPZM |
Epizyme, Inc. |
Chief Scientific Officer |
• – – |
2022-08-09 |
4 |
OE |
$1.39 |
$528,200 |
D/D |
380,000 |
474,563 |
0 |
- |
|
| EPZM |
Epizyme, Inc. |
Chief Scientific Officer |
• – – |
2022-04-11 |
4 |
AS |
$0.90 |
$2,467 |
D/D |
(2,741) |
94,563 |
0 |
% |
|
| EPZM |
Epizyme, Inc. |
Chief Scientific Officer |
• – – |
2022-02-02 |
4 |
AS |
$1.37 |
$3,502 |
D/D |
(2,556) |
97,304 |
0 |
% |
|
| EPZM |
Epizyme, Inc. |
Chief Scientific Officer |
• – – |
2021-08-16 |
4 |
A |
$0.00 |
$0 |
D/D |
45,832 |
99,860 |
0 |
- |
|
| EPZM |
Epizyme, Inc. |
Chief Scientific Officer |
• – – |
2021-04-05 |
4 |
AS |
$8.80 |
$17,855 |
D/D |
(2,029) |
54,028 |
0 |
% |
|
| EPZM |
Epizyme, Inc. |
Chief Scientific Officer |
• – – |
2021-02-01 |
4 |
A |
$0.00 |
$0 |
D/D |
28,645 |
56,057 |
0 |
- |
|
| EPZM |
Epizyme, Inc. |
Chief Scientific Officer |
• – – |
2020-04-01 |
4 |
A |
$0.00 |
$0 |
D/D |
27,412 |
27,412 |
0 |
- |
|
| INFI |
Infinity Pharmaceuticals ... |
Chief Scientific Officer |
• – – |
2020-01-10 |
4 |
A |
$0.00 |
$0 |
D/D |
64,219 |
77,376 |
0 |
- |
|
| INFI |
Infinity Pharmaceuticals ... |
Chief Scientific Officer |
• – – |
2018-08-16 |
4 |
AS |
$2.00 |
$12,266 |
D/D |
(6,133) |
0 |
0 |
- |
|
| INFI |
Infinity Pharmaceuticals ... |
Chief Scientific Officer |
• – – |
2018-08-15 |
4 |
AS |
$2.01 |
$16,421 |
D/D |
(8,180) |
6,133 |
0 |
- |
|
| INFI |
Infinity Pharmaceuticals ... |
Chief Scientific Officer |
• – – |
2018-06-22 |
4 |
AS |
$2.00 |
$28,695 |
D/D |
(14,313) |
14,313 |
0 |
- |
|
| INFI |
Infinity Pharmaceuticals ... |
Chief Scientific Officer |
• – – |
2018-01-02 |
4 |
A |
$0.00 |
$0 |
D/D |
28,626 |
28,626 |
0 |
- |
|
| INFI |
Infinity Pharmaceuticals ... |
Chief Scientific OfficerOffice |
• – – |
2017-02-10 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
2,072 |
|
- |
|
15 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
